Preclinical analysis of resistance and cross-resistance to low-dose metronomic chemotherapy.

Chow A, Wong A, Francia G, Man S, Kerbel RS, Emmenegger U. Preclinical analysis of resistance and cross-resistance to low-dose metronomic chemotherapy. Invest New Drugs. 2014 Feb; 32(1):47-59.

View in: PubMed

subject areas

Administration, Oral
Animals
Antineoplastic Combined Chemotherapy Protocols
Cell Line, Tumor
Cyclophosphamide
Dose-Response Relationship, Drug
Drug Resistance, Neoplasm
Fecal Impaction
Gene Expression Regulation, Neoplastic
Humans
Male
Mice
Mice, Nude
Oligonucleotide Array Sequence Analysis
Prostatic Neoplasms
Taxoids
Topotecan
Up-Regulation
Xenograft Model Antitumor Assays

authors with profiles

Giulio Francia

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support